BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fagoonee S, Pellicano R. Helicobacter pylori: molecular basis for colonization and survival in gastric environment and resistance to antibiotics. A short review. Infect Dis (Lond) 2019;51:399-408. [PMID: 30907202 DOI: 10.1080/23744235.2019.1588472] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Bonetto S, Gruden G, Beccuti G, Ferro A, Saracco GM, Pellicano R. Management of Dyspepsia and Gastroparesis in Patients with Diabetes. A Clinical Point of View in the Year 2021. J Clin Med 2021;10:1313. [PMID: 33806716 DOI: 10.3390/jcm10061313] [Reference Citation Analysis]
2 Kalatuwawege IP, Gunaratna MJ, Udukala DN. Synthesis, In Silico Studies, and Evaluation of Syn and Anti Isomers of N-Substituted Indole-3-carbaldehyde Oxime Derivatives as Urease Inhibitors against Helicobacter pylori. Molecules 2021;26:6658. [PMID: 34771067 DOI: 10.3390/molecules26216658] [Reference Citation Analysis]
3 Buxbaum JN. Unravelling Alzheimer's Disease: It's Not the Whole Story, but Aβ Still Matters. FASEB j 2019;33:9701-5. [DOI: 10.1096/fj.201901895] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Isaeva GS. Pangenomic studies of Helicobacter pylori: a key to understanding pathogenesis and human history. Minerva Biotecnol 2019;31. [DOI: 10.23736/s1120-4826.19.02564-3] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Raj R, Agarwal N, Raghavan S, Chakraborti T, Poluri KM, Kumar D. Exquisite binding interaction of 18β-Glycyrrhetinic acid with histone like DNA binding protein of Helicobacter pylori: A computational and experimental study. International Journal of Biological Macromolecules 2020;161:231-46. [DOI: 10.1016/j.ijbiomac.2020.06.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
6 Chen Y, Liu Q, Hu F, Ma J. Identifying the best regimen for primary eradication of Helicobacter pylori: analysis of 240 cases. Microbiologyopen 2020;9:e1120. [PMID: 33026166 DOI: 10.1002/mbo3.1120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhang N, Liu W, Qian K. In-vitro antibacterial effect of tea polyphenols combined with common antibiotics on multidrug-resistant Klebsiella pneumoniae. Minerva Med 2020;111:536-43. [PMID: 32340432 DOI: 10.23736/S0026-4806.20.06459-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mladenova I. The potential involvement of human microbiota in osteoarthritis: encouraging data useful for future studies. Minerva Med 2019;110:399-400. [PMID: 31124640 DOI: 10.23736/S0026-4806.19.06147-0] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Cheok YY, Lee CYQ, Cheong HC, Vadivelu J, Looi CY, Abdullah S, Wong WF. An Overview of Helicobacter pylori Survival Tactics in the Hostile Human Stomach Environment. Microorganisms 2021;9:2502. [PMID: 34946105 DOI: 10.3390/microorganisms9122502] [Reference Citation Analysis]
10 Valenzano M, Bisio A, Grassi G. Helicobacter pylori and diabetes mellitus: a controversial relationship. Minerva Endocrinol 2019;44:301-9. [PMID: 31304727 DOI: 10.23736/S0391-1977.19.03021-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Sun X, Zhang S, Ren J, Udenigwe CC. Sialic acid-based strategies for the prevention and treatment of Helicobacter pylori infection: Emerging trends in food industry. Critical Reviews in Food Science and Nutrition. [DOI: 10.1080/10408398.2020.1846157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Isaeva G, Isaeva R. Molecular methods for the detection of Helicobacter pylori. Minerva Biotecnol 2020;32. [DOI: 10.23736/s1120-4826.20.02665-8] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Chen Y, Yuan H, Ye H, Shi Z, Deng X, Zhang X, Hou X. Application of a semi-automatic, intensive follow-up for improving efficacy and adherence of Helicobacter pylori eradication therapy: A randomized controlled trial. Microbiologyopen 2021;10:e1172. [PMID: 33650799 DOI: 10.1002/mbo3.1172] [Reference Citation Analysis]
14 Smith SI, Jolaiya T, Fowora M, Ugiagbe R, Onyekwere C, Agbo I, Lesi O, Palamides P, Adedeji A, Ndububa D, Adekanle O, Adeleye I, Bamidele M, Ngoka F, Ayodeji I, Njom H, Pellicano R. Comparison of polymerase chain reaction-based genotyping of Helicobacter pylori by direct polymerase chain reaction from biopsies and cultures from patients with dyspepsia in Nigeria. Minerva Biotecnol 2019;31. [DOI: 10.23736/s1120-4826.19.02558-8] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
15 Mladenova I. Helicobacter pylori and cardiovascular disease: update 2019. Minerva Cardioangiol 2019;67:425-32. [PMID: 31343146 DOI: 10.23736/S0026-4725.19.04986-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Durazzo M, Adriani A, Fagoonee S, Saracco GM, Pellicano R. Helicobacter pylori and Respiratory Diseases: 2021 Update. Microorganisms 2021;9:2033. [PMID: 34683354 DOI: 10.3390/microorganisms9102033] [Reference Citation Analysis]
17 Hernández VM, Arteaga A, Dunn MF. Diversity, properties and functions of bacterial arginases. FEMS Microbiol Rev 2021:fuab034. [PMID: 34160574 DOI: 10.1093/femsre/fuab034] [Reference Citation Analysis]
18 Mosso E, Bonetto S, Longobardi G, Abenavoli L, Ribaldone DG, Saracco GM, Pellicano R. Management of functional dyspepsia in 2020: a clinical point of view. Minerva Gastroenterol Dietol 2020;66:331-42. [PMID: 32623872 DOI: 10.23736/S1121-421X.20.02732-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
19 Krzyżek P, Franiczek R, Krzyżanowska B, Łaczmański Ł, Migdał P, Gościniak G. In Vitro Activity of Sertraline, an Antidepressant, Against Antibiotic-Susceptible and Antibiotic-Resistant Helicobacter pylori Strains. Pathogens 2019;8:E228. [PMID: 31717683 DOI: 10.3390/pathogens8040228] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
20 Nemattalab M, Shenagari M, Taheri M, Mahjoob M, Nazari Chamaki F, Mojtahedi A, Hasan-Alizadeh E, Ashrafkhani B, Mousavi Niri N. Co-expression of Interleukin-17A molecular adjuvant and prophylactic Helicobacter pylori genetic vaccine could cause sterile immunity in Treg suppressed mice. Cytokine 2020;126:154866. [PMID: 31629103 DOI: 10.1016/j.cyto.2019.154866] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
21 Dávila-Collado R, Jarquín-Durán O, Dong LT, Espinoza JL. Epstein-Barr Virus and Helicobacter Pylori Co-Infection in Non-Malignant Gastroduodenal Disorders. Pathogens 2020;9:E104. [PMID: 32041355 DOI: 10.3390/pathogens9020104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
22 Zhao Q, Song C, Wang K, Li D, Yang Y, Liu D, Wang L, Zhou N, Xie Y. Prevalence of Helicobacter pylori babA, oipA, sabA, and homB genes in isolates from Chinese patients with different gastroduodenal diseases. Med Microbiol Immunol 2020;209:565-77. [PMID: 32219508 DOI: 10.1007/s00430-020-00666-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
23 Lee S, Sneed GT, Brown JN. Treatment of Helicobacter pylori with nitazoxanide-containing regimens: a systematic review. Infect Dis (Lond) 2020;52:381-90. [PMID: 31900002 DOI: 10.1080/23744235.2019.1708454] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Pellicano R, Ribaldone DG, Caviglia GP. Strategies for Helicobacter pylori eradication in the year 2020. Saudi J Gastroenterol 2020;26:63-5. [PMID: 32295934 DOI: 10.4103/sjg.SJG_95_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Mladenova I. Clinical Relevance of Helicobacter pylori Infection. J Clin Med 2021;10:3473. [PMID: 34441769 DOI: 10.3390/jcm10163473] [Reference Citation Analysis]
26 Bilello J, Okereke I. Impact of Environmental and Pharmacologic Changes on the Upper Gastrointestinal Microbiome. Biomedicines 2021;9:617. [PMID: 34072493 DOI: 10.3390/biomedicines9060617] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Ngaiza AI, Yahaya JJ, Mwakimonga AK, Vuhahula E, Mnango L, Mwakigonja AR, Kawishe GJ, Ng D. Histologic detection of Helicobacter pylori by the immunohistochemical method using anti-Helicobacter pylori polyclonal antibody: A cross-sectional study of patients with gastric pathologies at the Muhimbili National Hospital in Dar-es-salaam, Tanzania. Arab J Gastroenterol 2021:S1687-1979(21)00081-2. [PMID: 34840096 DOI: 10.1016/j.ajg.2021.11.002] [Reference Citation Analysis]
28 Wanibuchi K, Hosoda K, Amgalanbaatar A, Hirai Y, Shoji M, Shimomura H. A short review, effect of dimethyl-β-cyclodextrin on the interaction between Helicobacter pylori and steroidal compounds. Heliyon 2021;7:e06767. [PMID: 33912723 DOI: 10.1016/j.heliyon.2021.e06767] [Reference Citation Analysis]
29 Patrucco F, Venezia L, Nicali R, Pellicano R, Bellan M, Balbo PE. Idiopathic pulmonary fibrosis and gastroesophageal reflux. Minerva Pneumol 2020;59. [DOI: 10.23736/s0026-4954.20.01865-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Marinoni C, Ribaldone DG, Rosso C, Astegiano M, Caviglia GP. Diagnosis of Helicobacter pylori infection: a look into molecular aspects of urea breath test. Minerva Biotecnol 2019;31. [DOI: 10.23736/s1120-4826.19.02555-2] [Cited by in Crossref: 9] [Article Influence: 3.0] [Reference Citation Analysis]
31 Pedrood K, Azizian H, Montazer MN, Mohammadi-Khanaposhtani M, Asgari MS, Asadi M, Bahadorikhalili S, Rastegar H, Larijani B, Amanlou M, Mahdavi M. Arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitors. Sci Rep 2021;11:10607. [PMID: 34012008 DOI: 10.1038/s41598-021-90104-x] [Reference Citation Analysis]
32 Alsulaimany FAS, Awan ZA, Almohamady AM, Koumu MI, Yaghmoor BE, Elhady SS, Elfaky MA. Prevalence of Helicobacter pylori Infection and Diagnostic Methods in the Middle East and North Africa Region. Medicina (Kaunas) 2020;56:E169. [PMID: 32283700 DOI: 10.3390/medicina56040169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Jiang M, Ma L, Huang Y, Wu H, Dou J, Zhou C. Antimicrobial activities of peptide Cbf-K16 against drug-resistant Helicobacter pylori infection in vitro and in vivo. Microb Pathog 2020;138:103847. [PMID: 31704464 DOI: 10.1016/j.micpath.2019.103847] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
34 González-hormazábal P, Arenas A, Serrano C, Pizarro M, Fuentes-lópez E, Arnold J, Berger Z, Musleh M, Valladares H, Lanzarini E, Jara L, Castro VG, Camargo MC, Riquelme A. Prevalence of Helicobacter pylori Antimicrobial Resistance Among Chilean Patients. Archives of Medical Research 2021;52:529-34. [DOI: 10.1016/j.arcmed.2021.01.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]